These extremely important drugs reduce the number of infiltrating granulocytes and macrophages in the RA synovium, as well as the expression of IL-8, MCP-1, IL-1, IL-6, GM-CSF and chemokines [135]. This evidence concerns the gene CXCL8 and rheumatoid arthritis.